Logo image of NODK

NI HOLDINGS INC (NODK) Stock Fundamental Analysis

NASDAQ:NODK - Nasdaq - US65342T1060 - Common Stock - Currency: USD

12.69  -0.12 (-0.94%)

After market: 12.69 0 (0%)

Fundamental Rating

2

NODK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. NODK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NODK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NODK was profitable.
NODK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NODK reported negative net income in multiple years.
NODK had a positive operating cash flow in 4 of the past 5 years.
NODK Yearly Net Income VS EBIT VS OCF VS FCFNODK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

The Return On Assets of NODK (0.07%) is worse than 81.82% of its industry peers.
With a Return On Equity value of 0.15%, NODK is not doing good in the industry: 81.12% of the companies in the same industry are doing better.
With a decent Return On Invested Capital value of 2.92%, NODK is doing good in the industry, outperforming 60.84% of the companies in the same industry.
Industry RankSector Rank
ROA 0.07%
ROE 0.15%
ROIC 2.92%
ROA(3y)-3.54%
ROA(5y)-0.56%
ROE(3y)-8.61%
ROE(5y)-2.33%
ROIC(3y)N/A
ROIC(5y)N/A
NODK Yearly ROA, ROE, ROICNODK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

NODK has a Profit Margin of 0.11%. This is amonst the worse of the industry: NODK underperforms 81.82% of its industry peers.
NODK's Operating Margin of 5.41% is on the low side compared to the rest of the industry. NODK is outperformed by 72.73% of its industry peers.
In the last couple of years the Operating Margin of NODK has declined.
Industry RankSector Rank
OM 5.41%
PM (TTM) 0.11%
GM N/A
OM growth 3Y-0.51%
OM growth 5Y-22.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NODK Yearly Profit, Operating, Gross MarginsNODK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NODK is destroying value.
The number of shares outstanding for NODK has been increased compared to 1 year ago.
NODK has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, NODK has an improved debt to assets ratio.
NODK Yearly Shares OutstandingNODK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
NODK Yearly Total Debt VS Total AssetsNODK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

The Debt to FCF ratio of NODK is 0.01, which is an excellent value as it means it would take NODK, only 0.01 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.01, NODK belongs to the best of the industry, outperforming 93.01% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that NODK is not too dependend on debt financing.
The Debt to Equity ratio of NODK (0.00) is better than 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACC0.32
WACC9.07%
NODK Yearly LT Debt VS Equity VS FCFNODK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
NODK Yearly Current Assets VS Current LiabilitesNODK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 108.07% over the past year.
Looking at the last year, NODK shows a decrease in Revenue. The Revenue has decreased by -6.51% in the last year.
NODK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.62% yearly.
EPS 1Y (TTM)108.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.9%
Revenue 1Y (TTM)-6.51%
Revenue growth 3Y-0.05%
Revenue growth 5Y3.62%
Sales Q2Q%-18.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NODK Yearly Revenue VS EstimatesNODK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 634.50, NODK can be considered very expensive at the moment.
86.01% of the companies in the same industry are cheaper than NODK, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.68. NODK is valued rather expensively when compared to this.
Industry RankSector Rank
PE 634.5
Fwd PE N/A
NODK Price Earnings VS Forward Price EarningsNODK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NODK indicates a rather cheap valuation: NODK is cheaper than 88.81% of the companies listed in the same industry.
62.94% of the companies in the same industry are cheaper than NODK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.37
EV/EBITDA 2.35
NODK Per share dataNODK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NODK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NI HOLDINGS INC

NASDAQ:NODK (5/16/2025, 8:08:12 PM)

After market: 12.69 0 (0%)

12.69

-0.12 (-0.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-06 2025-08-06
Inst Owners25%
Inst Owner Change1.14%
Ins Owners6.39%
Ins Owner Change0.65%
Market Cap262.68M
Analysts0
Price TargetN/A
Short Float %0.52%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 634.5
Fwd PE N/A
P/S 0.77
P/FCF 15.37
P/OCF 14.53
P/B 1.07
P/tB 1.07
EV/EBITDA 2.35
EPS(TTM)0.02
EY0.16%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.83
FCFY6.5%
OCF(TTM)0.87
OCFY6.88%
SpS16.42
BVpS11.82
TBVpS11.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.15%
ROCE 3.62%
ROIC 2.92%
ROICexc 3.25%
ROICexgc 3.45%
OM 5.41%
PM (TTM) 0.11%
GM N/A
FCFM 5.03%
ROA(3y)-3.54%
ROA(5y)-0.56%
ROE(3y)-8.61%
ROE(5y)-2.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y5.36%
ROICexcg growth 5Y-20.33%
ROICexc growth 3Y6.56%
ROICexc growth 5Y-20.75%
OM growth 3Y-0.51%
OM growth 5Y-22.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 1.38%
Cap/Sales 0.29%
Interest Coverage 250
Cash Conversion 20.01%
Profit Quality 4759.33%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score9
WACC9.07%
ROIC/WACC0.32
Cap/Depr(3y)1.35%
Cap/Depr(5y)1.21%
Cap/Sales(3y)0.28%
Cap/Sales(5y)0.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.51%
Revenue growth 3Y-0.05%
Revenue growth 5Y3.62%
Sales Q2Q%-18.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4024.89%
EBIT growth 3Y-0.56%
EBIT growth 5Y-19.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.04%
FCF growth 3Y-15.65%
FCF growth 5Y-6.86%
OCF growth 1Y-22.93%
OCF growth 3Y-14.74%
OCF growth 5Y-6.77%